The zen3694 x enzalutimide mCRPC study has been going on for a long time. Now zen3694 is in numerous trials. If Zenith could strike a contract with any major BP it could put some real value in Zenith shares.

The problem as I recall it most of the science results are in the distant future.

The good news is that Don told us years ago that we'ed be surprised at how fast cancer trials move.    :)

Just a thought. I guess we just wait and wait.

Toinv